Suppressive mechanisms of Sairei-to on mesangial matrix expansion in rat mesangioproliferative glomerulonephritis

Nephron - Experimental Nephrology

Volumn 100, Issue 3, 2005, Pages

  Ono, Takahiko ^a,c   Liu, Ning ^a   Makino, Toshiaki ^a   Nogaki, Fumiaki ^a   Muso, Eri ^b   Honda, Gisho ^a   Kita, Toru ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Kitano Hospital   (Japan)

^c UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Connective tissue growth factor; IgA nephropathy; Sairei to; Superoxide dismutase; Transforming growth factor

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; CYTOKINE; ENDOTHELIN 1; FIBRONECTIN; MESSENGER RNA; PREDNISOLONE; PROTEIN; SAIBOKU TO; SAIREI TO; SUPEROXIDE DISMUTASE; THYMOCYTE ANTIBODY; TRANSFORMING GROWTH FACTOR; WATER; XIAO CHAI HU TANG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL INFILTRATION; DRINKING; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; GLOMERULUS; HERBAL MEDICINE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INJECTION; KIDNEY; KIDNEY CORTEX; KIDNEY HOMOGENATE; MACROPHAGE; MESANGIUM CELL; NONHUMAN; NORTHERN BLOTTING; PRESCRIPTION; PRIORITY JOURNAL; PROLIFERATIVE GLOMERULONEPHRITIS; PROTEIN EXPRESSION; PROTEIN URINE LEVEL; PROTEINURIA; RAT; UPREGULATION;

ANIMALS; DRUGS, CHINESE HERBAL; EXTRACELLULAR MATRIX; GLOMERULONEPHRITIS, MEMBRANOPROLIFERATIVE; HUMANS; IMMEDIATE-EARLY PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY CORTEX; MACROPHAGES; MALE; PROTEINURIA; RATS; RATS, WISTAR; RNA, MESSENGER; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION;

EID: 20944437490     PISSN: 16602129     EISSN: None     Source Type: Journal    
DOI: 10.1159/000085059     Document Type: Article

References (37)

1. Emancipator SN, Lamm ME: IgA nephropathy: pathogenesis of the most common form of glomerulonephritis. Lab Invest 1989;60:168-183.
2. Chauveau D, Droz D: Follow-up evaluation of the first patients with IgA nephropathy described at Necker Hospital; in Béné MC, Faure G, Kesseler M (eds): IgA Nephropathy. The 25th Year. Contrib Nephrol. Basel, Karger, 1993, pp 1-5.
3. Strippoli GF, Manno C, Schena FP: An 'evidence-based' survey of therapeutic options for IgA nephropathy: Assessment and criticism. Am J Kidney Dis 2003;41:1129-1139.
4. Floege J: Evidence-based recommendations for immunosuppression in IgA nephropathy: handle with caution. Nephrol Dial Transplant. 2003;18:241-245.
5. Ono T, Yashiro M, Oyama A, Yoshida H, Muso E, Sasayama S: Inhibitory effect of the herbal medicine Saiboku-to on the proliferation of cultured murine mesangial cells. Nephrol 1998;4:367-372.
6. Mitani K, Nagai Y, Oneyama T: Treatment for thirthty and nausea; in Yakazu K, Matsushita K (eds): Japanese Traditional Medicine (in Japanese). Tokyo, Midori Shobo, 1999, pp 758-759, 815-818.
7. Nagata M, Kawaguchi H, Komatsu Y, Hattori M, Itoh K: The effects of Sairei-to on nephrotoxic serum nephritis in rats. Possible effects on intraglomerular cell mediated immunity (in Japanese). Nippon Jinzo Gakkai Shi 1989;31:713-721.
8. Joarder ZH, Ogawa T, Yorioka N, Yamakido M: Studies on the effectiveness of Sairei-to on puromycin aminonucleoside nephrosis in rats. Hiroshima J Med Sci 1991;40:127-135.
9. Hattori T, Shindo S: Effects of Sairei-to (TJ-114) on the expression of adhesion molecule in anti-GBM nephritic rats (in Japanese). Nippon Jinzo Gakkai Shi 1995;37:373-383.
10. Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M: A prospective controlled study of sairei-to in childhood IgA nephropathy with focal/minimal mesangial proliferation. Nippon Jinzo Gakkai Shi 1997;39:503-506.
11. Floege J, Johnson RJ, Gordon K, Iida H, Pritzl P, Yoshimura A, Campbell C, Alpers CE, Couser WG: Increased synthesis of extracellular matrix in mesangial proliferative nephritis. Kidney Int 1991;40:477-488.
12. Li P, Kawachi H, Morioka T, Orikasa M, Oite T, Shi ZS, Shimizu F: Suppressive effects of Sairei-to on monoclonal antibody 1-22-3-induced glomerulonephritis: analysis of effective components. Pathol Int 1997;47:430-435.
13. Ishizaki M, Masuda Y, Fukuda Y, Sugisaki Y, Yamanaka N, Masugi Y: Experimental mesangioproliferative glomerulonephritis in rats induced by intravenous administration anti-thymocyte serum. Acta Pathol Jpn 1986;36:1191-1203.
14. Liu N, Ono T, Suyama K, Nogaki F, Shirakawa K, Maeda M, Kawamura T, Kamata T, Oyama A, Muso E, Sasayama S: Mesangial factor V expression colocalized with fibrin deposition in IgA nephropathy. Kidney Int 2000;58:598-606.
15. Higuchi Y, Ono K, Sekita S: Preventive effects of Shichimotsu-koka-to on renal lesions in stroke-prone spontaneously hypertensive rats. Biol Pharm Bull 1998;21:914-918.
16. Nogaki F, Muso E, Yashiro M, Kasuno K, Kamata T, Ono T, Sasayama S: Direct effects of simvastatin on proliferation and matrix accumulation in cultured murine mesangial cells. Clin Exp Nephrol 2001;5:85-89.
17. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-159.
18. Okuda S, Languino LR, Ruoslahti E, Border WA: Elevated expression of transforming growth factor-beta and proteoglycan production in experimental glomerulonephritis: Possible role in expansion of the mesangial extracellular matrix. J Clin Invest 1990;86:453-462.
19. Border WA, Noble NA: TGF-β in kidney fibrosis: A target for gene therapy. Kidney Int 1997;51:1388-1396.
20. Ito Y, Goldschmeding R, Bende RJ, Claessen N, Chand MA, Kleij L, Rabelink TJ, Weening JJ, Aten J: Kinetics of connective tissue growth factor expression during experimental proliferative glomerulonephritis. J Am Soc Nephrol 2001;12:472-484.
21. Ito Y, Aten J, Bende RJ, Oemar BS, Rabelink TJ, Weening JJ: Expression of connective tissue growth factor in human renal fibrosis. Kidney Int 1998;53:853-861.
22. Haraguchi M, Border WA, Huang Y, Noble NA: t-PA promotes glomerular plasmin generation and matrix degradation in experimental glomerulonephritis. Kidney Int 2001;59:2146-2155.
23. Ferrario F, Castiglione A, Colasanti G, Barbiano di Belgioioso G, Bertoli S, D'Amico G: The detection of monocytes in human glomerulonephritis. Kidney Int 1985;28:513-519.
24. Bagchus WM, Jeunink MF, Elema JD: The mesangium in anti-Thy-1 nephritis. Influx of macrophages, mesangial cell hypercellularity, and macromolecular accumulation. Am J Pathol 1990;137:215-223.
25. Ito T, Seo N, Yagi H, Ohtani T, Tokura Y, Takigawa M, Furukawa F: Unique therapeutic effects of the Japanese-Chinese herbal medicine, Sairei-to, on Th1/Th2 cytokines balance of the autoimmunity of MRL/1pr mice. J Dermatol Sci 2002;28:198-210.
26. Nakamura K, Oka M, Shirai M, Igarashi Y, Kojima K, Kaneko O, Hamada N, Mera J, Masaoka H, Nagase M: Source of reactive oxygen species in anti-thy-1 nephritis. Ren Fail 1998;20:399-405.
27. Hamada N, Nagase M: In vivo effect of OPC15161, a superoxide scavenger, on anti-thy-1 nephritis. Eur J Pharmacol 1996;317:123-128.
28. Bochorakova H, Paulova H, Slanina J, Musil P, Taborska E: Main flavonoids in the root of Scutellaria baicalensis cultivated in Europe and their comparative antiradical properties. Phytother Res 2003;17:640-644.
29. Nakamura Y, Ohto Y, Murakami A, Ohigashi H: Superoxide scavenging activity of rosmarinic acid from Perilla frutescens Britton var. acuta f. viridis. J Agri Food Chem 1998;46:4545-4550.
30. Matsuda H, Kageura T, Toguchida I, Murakami T, Kishi A, Yoshikawa M: Effects of sesquiterpenes and triterpenes from the rhizome of Alisma orientale on nitric oxide production in lipopolysaccharide-activated macrophages: absolute stereostructures of alismaketones-B 23-acetate and -C 23-acetate. Bioorg Med Chem Lett 1999;9:3081-3086.
31. Hattori T, Fujitsuka N, Kurogi A, Shindo S: Saire-to may inhibit the synthesis of endothelin-1 in nephritic glomeruli (in Japanese). Nippon Jinzo Gakkai Shi 1997;39:121-128.
32. Hattori T, Nishimura H, Makino B, Shindo S, Kawamura H: Sairei-to inhibits the production of endothelin-1 by nephritic glomeruli (2): Alisols, possible candidates as active compounds (in Japanese). Nippon Jinzo Gakkai Shi 1998;40:33-41.
33. Rastaldi MP, Tunesi S, Ferrario F, Indaco A, Zou H, Napodano P, D'Amico G: Transforming growth factor-beta, endothelin-1, and c-fos expression in necrotizing/crescentic IgA glomerulonephritis. Nephrol Dial Transplant 1998;13:1668-1674.
34. Saegusa Y, Sugiyama A, Takahara A, Nagasawa Y, Hashimoto K: Relationship between phosphodiesterase inhibition induced by several Kampo medicines and smooth muscle relaxation of gastrointestinal tract tissues of rats. J Pharmacol Sci 2003;93:62-68.
35. Awazu M, Fujita H, Omori S, Hida M: The herbal medicine Sairei-to inhibits proliferation of rat mesangial cells. Nephron 2002;92:652-659.
36. Corbel M, Germain N, Lanchou J, Molet S, R e Silva PM, Martins MA, Boichot E, Lagente V: The selective phosphodiesterase 4 inhibitor RP 73-401 reduced matrix metalloproteinase 9 activity and transforming growth factor-beta release during acute lung injury in mice: The role of the balance between tumor necrosis factor-alpha and interleukin-10. J Pharmacol Exp Ther 2002;301:258-265.
37. Hayashida T, Decaestecker M, Schnaper HW: Cross-talk between ERK MAP kinase and Smad signaling pathways enhances TGF-beta-dependent responses in human mesangial cells. FASEB J 2003;17:1576-1578.